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Abstract
Pseudomonas aeruginosa type III secretion apparatus exports and translocates four exotoxins into the cytoplasm of the host
cell. The translocation requires two hydrophobic bacterial proteins, PopB and PopD, that are found associated with host cell
membranes following infection. In this work we examined the influence of host cell elements on exotoxin translocation
efficiency. We developed a quantitative flow cytometry based assay of translocation that used protein fusions between
either ExoS or ExoY and the ß-lactamase reporter enzyme. In parallel, association of translocon proteins with host plasma
membranes was evaluated by immunodetection of PopB/D following sucrose gradient fractionation of membranes. A pro-
myelocytic cell line (HL-60) and a pro-monocytic cell line (U937) were found resistant to toxin injection even though PopB/D
associated with host cell plasma membranes. Differentiation of these cells to either macrophage- or neutrophil-like cell lines
resulted in injection-sensitive phenotype without significantly changing the level of membrane-inserted translocon
proteins. As previous in vitro studies have indicated that the lysis of liposomes by PopB and PopD requires both cholesterol
and phosphatidyl-serine, we first examined the role of cholesterol in translocation efficiency. Treatment of sensitive HL-60
cells with methyl-ß-cyclodextrine, a cholesterol-depleting agent, resulted in a diminished injection of ExoS-Bla. Moreover,
the PopB translocator was found in the membrane fraction, obtained from sucrose-gradient purifications, containing the
lipid-raft marker flotillin. Examination of components of signalling pathways influencing the toxin injection was further
assayed through a pharmacological approach. A systematic detection of translocon proteins within host membranes
showed that, in addition to membrane composition, some general signalling pathways involved in actin polymerization
may be critical for the formation of a functional pore. In conclusion, we provide new insights in regulation of translocation
process and suggest possible cross-talks between eukaryotic cell and the pathogen at the level of exotoxin translocation.
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Introduction
Pseudomonas aeruginosa is a major Gram negative, opportunistic
human pathogen associated with a variety of acute and chronic
diseases. The bacterium can invade different tissues including
respiratory and urinary tracts, damaged and burned skin, or
injured cornea [1]. Patients with genetic disorder leading to cystic
fibrosis are especially susceptible to chronic P. aeruginosa infection,
which in turn contributes to morbidity and increased mortality. In
the last decades, P. aeruginosa infections became a serious health
problem as these bacteria are becoming multi-resistant to most
existing antimicrobial treatments [2].
Pseudomonas aeruginosa is especially well equipped with numer-
ous pathogenic mechanisms contributing to its virulence.
Among six secretion systems found in Gram negative bacteria,
P. aeruginosa possesses five of them, and some in several copies
[3]. Type III secretion (T3S) machinery, conserved in a variety
of Gram negative pathogens, is dedicated to export and
translocation directly into eukaryotic cell cytoplasm of four
exotoxins (ExoS, ExoT, ExoY and ExoU) [4]. These macro-
molecules have dramatic effects on signal transduction pathways
and actin cytoskeleton, leading to cell dysfunction and, in some
cases, cell mortality [5]. The passage of the exotoxins across the
three membranes is performed by a complex nanostructure
composed of at least twenty distinct proteins that associate in
three sub-assemblies. The basal body, called the secreton, is
spanning the two bacterial membranes by several superposed
ring-like homo-oligomers [6]. Protruding outwards and in
continuum with the basal body, the so-called T3S needle is
composed of one protein, PscF in P. aeruginosa, that polymerizes
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supposed to be a conduit for exported substrates [7]. The first
proteins proposed to be exported through the needle are PcrV,
PopB and PopD, playing an essential role in toxin translocation
across the plasma membrane of target cell [8,9]. As a majority
of T3S substrates, the three translocators are kept in bacterial
cytoplasm in complexes with their cognate chaperons, PcrG for
PcrV, and PcrH shared by PopB and PopD [10,11,12,13]. PcrV
belongs to a family of surface-exposed, soluble antigens, some of
them shown to oligomerize on the secretion needle extremity
[14,15,16,17]. The essential role of PcrV in T3S function is
clearly linked to insertion into the host membrane of two
hydrophobic translocators, PopB and PopD [15,18]. In all T3SS
studied to date, the largest translocator (in P. aeruginosa,P o p B )
harbours two putative transmembrane domains, while the
smallest protein (PopD) belongs to a subfamily of translocators
possessing only one transmembrane domain [9,11,19]. After
infection of erythrocytes, PopB and PopD remain associated
with the plasma membrane, while the PcrV translocator stays
bacteria-associated [15,18]. Both translocators purified in vitro,
bind to phosphatidylserine-charged liposomes and are capable
of inducing the release of small-molecular weight substances
[20]. Moreover, liposomes charged with cholesterol are
particularly vulnerable and ared i s r u p t e di nt h ep r e s e n c eo f
the translocator PopB [19] indicating the translocon preference
for specific lipid environments. The translocator SipB of
Salmonella has been shown to directly interact with cholesterol
[21] and Shigella homologue IpaD binds to a lipid raft-associated
eukaryotic protein CD44 [22]; in both cases cholesterol was
shown to be required for efficient bacterial invasion of host cell
[22,23]. A regulation of the translocation process itself has been
suggested for P. aeruginosa and Yersinia systems, where a
translocated effector provides a feedback control by modulating
an activity of yet-unknown host cell factor [8,24]. Hence, the
GTPase Activating Protein (GAP) domain of the effector YopE
is essential for controlling Yersinia translocation efficiency
probably by acting on actin cytoskeleton [25]. Recently, a
unique Yersinia protein, YopK/YopQ, has been identified as
playing an independent role in controlling YopB/D translocon
function once being itself translocated into cells [26]. Further-
more, P. aeruginosa and Yersinia spp. T3SS show some host
specificities both in vivo and in vitro [27,28,29], which might
result from the differential expression of host components
required for full T3S function. In this context HL-60 cells was
the first cell line identified as non-permissive to ExoS
intoxication [27]. In order to study the translocon function in
P. aeruginosa-cellular infection model, we set up a quantitative
effector translocation assay that relies on a ß-lactamase activity
fused downstream of inactive ExoS or ExoY N-terminal
domains. After infection, the activity of the reporter injected
in cells was measured by flow-cyt o m e t r y .T h ep r e s e n c eo fP o p
translocator proteins within host membranes was correlated
with data on the translocation of reporter protein. This
approach allowed us to demonstrate that insertion of translo-
cators into membranes can occur without efficient effector
translocation, as exemplified in T3S-resistant cells, HL-60 and
U937. We showed that cholesterol-depleting agent methyl-ß-
cyclodextrine, as well as several inhibitors of eukaryotic signal
transduction pathways, inhibits the translocation of the
reporters without affecting expression, export and association
of Pop proteins with host cell membranes. These results further
corroborate the idea that host-pathogen cross-talk is particularly
important in T3S function and may influence the efficiency of
effector injection.
Results
We showed previously that the activity of T3S translocon of P.
aeruginosa can be modulated in vitro by lipid content and pH
[19,20]. To analyse the translocon activity in vivo, we adapted a
reporter system based on Bla/CCF2 enzyme/substrate combina-
tion [29] to P. aeruginosa T3SS. This system enables single-cell
reproducible quantification of exotoxin translocation into host cells
using a flow-cytometry based analysis.
ExoS-Bla is an adequate reporter for measuring the T3S
translocation efficiency
The ExoS-Bla fusion was constructed so that its expression is
directed by a cognate exoS promoter and the secretion and
translocation of the fusion is achieved by the N-terminal ExoS
sequences, in which the GTPase activating protein (GAP) activity
was inactivated by the R146A mutation (see Materials and
Methods). In-frame fusion with ß-lactamase was introduced in the
different P. aeruginosa strains. The secretion of the fusion was
evaluated by probing culture supernatants. As shown by
immunoblotting using anti-ExoS antibodies (Figure 1A), the
ExoS-Bla fusion was efficiently secreted from the wild-type P.
aeruginosa strain CHA upon the induction of the system in vitro by
Ca
2+ depletion of the medium. The secretion of ExoS-Bla in the
medium was strictly dependent on the functional T3SS needle
composed by polymerized PscF. Translocon mutants, CHAD-
PopB/D and CHADPcrV secreted ExoS-Bla but they were unable
to inject the chimeric toxin in host cell cytoplasm (Figure 1B). To
obtain maximal ExoS-Bla secretion, the endogenous exoS gene was
deleted, so that no competition for the cognate chaperon and/or
for other secreton components would influence full ExoS-Bla
export. The translocation of ExoS-Bla was first tested on the
epithelial cell line A549. After incubation of cells with different
strains harbouring the fusion, the cells were incubated with ß-
lactamase fluorescent substrate CCF2-AM and analysed by
fluorescence microscopy. In parallel, the quantification was done
by flow-cytometry based assay (Figure 1B). The CCF2 cleavage
accomplished by a translocated fusion induces the disruption of
FRET (Fluorescence Resonance Energy Transfer) and provokes a
shift from green to blue fluorescence. While uninfected cells or
cells infected with CHADPopB/D showed only a low mean
fluorescence intensity (MFI) of about 3, the MFI reached a value of
16 when cells were co-incubated with the CHADS/ExoS-Bla
strain (Figure 1B). Consistent with a competition between ExoS-
Bla and endogenous ExoS observed in vitro (Figure 1A), the MFI
observed with the strain CHA-SBla was 2.3 fold lower than that
observed with CHADS-SBla (MFI 6.8 versus 16, respectively). The
translocation efficiency was in the same range when using the
CHADS-SBla strain (MFI 16) or the widely used PAO1 strain
(MFI 14.5) deleted of all three exotoxins (PAO1DSTY, [31])
(Figure 1B). Consequently, all the following experiments were
performed either with CHADS or PAO1DSTY strains. As
observed in Figure 1B, the second reporter, ExoY-Bla, behaved
as ExoS-Bla. Both reporters were translocated with the same
efficiency in A549 cells infected with PAO1DSTY-YBla and
PAO1DSTY-SBla (MFI 13.5 vs 14.5).
Undifferentiated pro-myelocytic HL-60 and pro-
monocytic U937 cell lines are resistant to T3S
translocation
We then examined the translocation of ExoS-Bla in several
eukaryotic cell types, including epithelial cell line A549, two
lymphoid cell lines Jurkat and BJAB, as well as the pro-myelocytic
HL-60 and the pro-monocytic U937 cell lines. As quantified by
T3S Translocon Regulation
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sensitive to ExoS-Bla injection with about 80% of cells being
injected at 3 h post-infection using a multiplicity of infection
(MOI) of 10 (Figure 2A). In contrast, undifferentiated HL-60 and
U937 cell lines were found refractory to ExoS-Bla and ExoY-Bla
injection (Figure 2B). The inability to detect ExoS- or ExoY-Bla
into resistant cells was not due to an artefact of inhibition or
degradation of b-lactamase or to an inefficient loading of the
CCF2 ß-lactamase substrate, since a HL-60 cell line that stably
expressed ß-lactamase efficiently cleaved CCF2 (Data not shown).
We then differentiated HL-60 cells into either neutrophil-like cells
with dimethyl-sulfoxide (DMSO), macrophage-like cells with
Phorbol Myristate Acetate (PMA) or monocyte-like cells with 1,2
3 dihydroxy-Vitamin D3 (VD3), as described in Materials and
Methods. The differentiation state was assayed by following the
expression of the macrophage/monocyte antigen, CD11b on cell
surface by flow cytometry (Figure 2C). Interestingly, all three
ways of differentiation provoked reversal from resistant to
susceptible phenotype, albeit the injection of ExoS-Bla was
significantly lower with macrophage-like cells (Figure 2A). These
results corroborate previous observation showing that undifferen-
tiated HL-60 cells are resistant to intoxication by ExoS [27] and
identify a novel cell line (U937) showing a similar phenotype. The
two undifferentiated cell lines were found to be resistant to
injection of ExoY-Bla fusion, whereas differentiated cells were
readily injected following infection (Figure 2B). Therefore, the
resistance of pro-myelocytic and pro-monocytic cells is not limited
to ExoS sequences, but could be linked to the general translocation
process itself.
Translocon insertion into HL-60 membranes is
independent of cell differentiation
The absence of injection of ExoS-Bla and ExoY-Bla fusions
within undifferentiated pro-myelocytic or pro-monocytic cell lines
after infection could be due to the absence of translocon insertion.
In P. aeruginosa, as well as in Yersinia, two hydrophobic
translocators, PopB/YopB and PopD/YopD, insert into erythro-
cytes plasma membranes and could be detected by specific
antibodies following cell fractionation by centrifugation on sucrose
gradients [15,18]. In these experiments, the hydrophilic translo-
cators, PcrV/LcrV, are not associated with membranes and are
used as a negative control for membrane purifications [15,18]. To
get further insights into the function of the translocon, we first
examined the presence of Pop proteins in membranes derived
from either injection resistant or injection permissive cells (i.e.
undifferentiated HL-60 versus differentiated HL-60 cells, referred
to as VD3-dHL-60 cells). To do so, infected host cell membranes
were submitted to fractionation by centrifugation on sucrose
gradients [30]. As expected, immunoblotting analysis of the
different fractions revealed that PopB and PopD were readily
inserted in the plasma membrane of permissive cells (Figure 3A).
Both proteins were also found associated with membranes of non-
permissive, undifferentiated HL-60 cells, suggesting that the defect
of ExoS and ExoY translocation was not due to the absence of
translocator proteins within the host cell membranes (Figure 3A).
Similarly, PopB was recovered in the membranes from infected
Figure 1. Characterization of ExoS-Bla and ExoY-Bla reporters. A/ Secretion profiles of P. aeruginosa strains carrying the reporter fusion ExoS-
Bla. Fifteen mL of culture supernatants of either wild-type CHA strain or mutant CHA strains expressing ExoS-Bla grown under T3SS-inducing
conditions were analyzed by immunoblotting with antibodies directed against ExoS, PopB, PopD and PcrV. B/ Co-cultures of A549 cells with
P. aeruginosa strains for 3 h at MOI 10. Injection of either ExoS-Bla or ExoY-Bla fusions by strains CHA and PAO1DSTY was detected after incubating
cells with b-lactamase substrate CCF2-AM either by fluorescence microscopy using a 206objective (upper panel) or by flow cytometry (lower panel).
The horizontal bar in flow-cytometry histograms indicates the gating used to determine the percentage of b-lactamase positive cells revealing ExoS-
Bla injection. Mean Fluorescence Intensity is indicated in each panel. Scale bar, 100 mm.
doi:10.1371/journal.pone.0030488.g001
Figure 2. Efficiency of ExoS-Bla and ExoY-Bla translocation in
different cell lines. A/ A549 epithelial cells, BJAB, Jurkat, non-
differentiated HL-60 cells (HL-60), or HL-60 differentiated into neutro-
phils, macrophages and monocytes by DMSO, PMA or Vitamin D3 (VD3),
respectively, were infected at MOI of 10, for 3 h, with CHADS expressing
ExoS-BlaR146A and analyzed by flow cytometry. B/ HL-60 and U937
were differentiated in monocytes with VD3 (black bars) or not (white
bars) and infected at MOI 10 with PAO1DSTY strains expressing either
ExoS-BlaR146A or ExoY-Bla as described above. The error bars indicate
standard deviation (n=3). C/ Non-differentiated HL-60 (thin lane) or HL-
60 differentiated in neutrophils (dot line), monocytes (dash line) or
macrophage (thick line) were labelled with a FITC conjugated antibody
specific for CD11b and analysed by flow cytometry.
doi:10.1371/journal.pone.0030488.g002
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shown). To ascertain that the detection of PopB/D was not
resulting from a contamination of the membranes by bacteria, we
first analysed samples of purified membranes for the presence of
PcrV. As shown in Figure 3A, no PcrV protein could be detected
by immunoblotting in the membrane prepared from infected HL-
60 cells. This lack of detection is not due to the anti-PcrV antibody
as evidenced by the detection of PcrV either in the supernatant of
P. aeruginosa (Figure 3C lane ‘‘Pa sup.’’) or as a His-tagged
recombinant protein (Figure 3C lane ‘‘PcrV’’). To further
confirm that the presence of PopB/D in the membrane
preparation was not due to residual bacteria, we used an antibody
specific for bacterial RNA polymerase subunit A (RpoA). This
antibody allowed the detection of as few as 2.10
5 bacteria, i.e.
0.04% of the bacterial input used to infect cells. As illustrated in
Figure 3B, only trace amounts of RpoA and PopB were detected
in bacteria lysates corresponding to an input of 2.10
5 bacteria
(lanes 4 and 6). After infection of HL-60 cells, RpoA was hardly
detectable in plasma membranes purified on sucrose gradient
(lanes 1 and 2), whereas huge amounts of PopB were associated
with membrane from undifferentiated HL-60 (lane 1) and VD3-
dHL-60 cells (lane 2). This strongly suggests that the recovery of
PopB/D results from the specific insertion of translocon in cell
membranes and not from contaminating bacteria attached to
infected cells. Altogether our results show that even though the
injection of effectors occurs only in differentiated cells, the
association of PopB/D translocators to membranes occurs equally
well in both non-permissive and permissive cells. This suggests the
implication of host components in translocon assembly and/or
functionality.
ExoS-Bla translocation occurs at the level of lipid rafts
In vitro, P. aeruginosa translocators PopB and PopD efficiently
disrupt artificial membranes (liposomes) only in presence of
cholesterol [19], which is one of the host cell lipid components
required for Shigella IpaB and Salmonella SipB translocator function
[21,23]. Moreover, cholesterol-rich membrane microdomains
have been implicated in invasion of P. aeruginosa [31]. To
investigate the role of cholesterol in exotoxin translocation, we
treated permissive HL-60 cells with methyl-ß-cyclodextrine
(MeßCD) and measured the level of ExoS-Bla injection. As shown
in Figure 4A, the injection of ExoS-Bla was inhibited byMeßCD
in a dose-dependent manner, reaching 50% of inhibition at 3 mM
concentration. Higher concentrations of MeßCD induced cell
mortality and were not taken into account. Of note, MeaCD, an
inactive isomer of MeßDC, used at concentrations up to 20 mM,
had no influence on ExoS-Bla injection. As cholesterol is the major
building block of specialized glycolipoprotein micro-domains
known as lipid rafts or detergent-resistant membranes (DRM),
we specifically purified DRM from infected cells by ultracentri-
fugation on sucrose gradients following treatment with Triton X-
100 at 4uC (see Materials and Methods), and the collected
fractions were analysed for the presence of translocators. As shown
on Figure 4B, in the case of infected VD3-dHL-60 cells, a
portion of PopB was found preferentially associated with lipid rafts
as it co-fractionated with flotillin, an eukaryotic lipid raft marker.
Using the same protocol to purify lipid rafts from the injection
resistant non-differentiated HL-60 cells, we systematically detected
a truncated PopB protein (PopB*) that co-fractionated with
flotillin. PopB was shortened by approximately 6 kDa, in spite of
the addition of several cocktails of protease inhibitors. Thus,
although PopB was recovered in both cases in the cholesterol rich
membranes, it is differentially susceptible to proteolytic cleavage.
Alteration of translocation efficiency by inhibitors of
eukaryotic signalling pathways
In order to decipher more in detail the eukaryotic elements and
signalling pathways that influence the PopB/D translocon activity,
Figure 3. PopB/D proteins presence in the membrane of
permissive and resistant cells is strictly due to translocon
insertion. A/ Non-differentiated HL-60 cells (ND) or VD3-differentiated
HL-60 cells (VD3) were infected with CHADS-SBlaR146A for 3 h, at MOI
50, or not infected (Ni). After three washes, plasma membranes were
purified by sucrose gradient centrifugation. The same amounts of
plasma membrane proteins (7 mg) were separated by SDS-PAGE and
revealed by immunoblotting with antibodies specific for PopB, PopD,
PcrV, LAT2 or flotillin. B/ After infection as above, non-differentiated
and VD3-differentiated HL-60 cells were washed three times, treated to
prepare plasma membrane fractions, and analysed by SDS-PAGE (lane 1
and 2, respectively) and immunoblotting for the presence of RpoA and
PopB. Aliquots of supernatants corresponding to 2.10
6 or 2.10
5 bacteria
incubated with undifferentiated HL-60 cells (lane 3 and 4) or with VD3-
differentiated HL-60 cells (lane 5 and 6) were lysed and analysed as
above. C/ Calibration of antibodies used in panel A and B. 0.3 ng of
recombinant proteins PopB, PopD and His-tagged PcrV and 20 mlo f
induced P. aeruginosa were loaded on SDS-PAGE, transferred and
revealed by immunoblotting with antibodies specific for PopB, PopD or
PcrV.
doi:10.1371/journal.pone.0030488.g003
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injection of ExoS-Bla within permissive VD3-dHL-60 cells by flow
cytometry. None of the inhibitors had an effect on ß-lactamase
activity itself, as verified by using a HL-60 cell line stably
expressing ß-lactamase (not shown) or on T3SS dependent Exo-
SBla secretion as shown in Figure 5C.
It is known that the level of cholesterol alters the viscoelastic
properties of the plasma membrane and, thereby, regulates the
actin-mediated deformation of the plasma membrane at the
leading edge of moving cells [32]. We therefore examined whether
the injection of ExoS-Bla required a functional actin network by
treating cells during infection with two compounds affecting actin
dynamics, cytochalasin D and latrunculin B [33]. At concentra-
tions that did not alter cell viability, bacterial growth and T3SS
dependent secretion in vitro, both molecules totally inhibited ExoS-
Bla translocation (Figure 5A). As F-actin polymerization is under
the control of the Rho family GTPases, we examined the
translocation efficiency after treatment with inhibitors that directly
target these GTPases or their effectors. In our hands, the
translocation of ExoS-Bla was not impaired either by the cell
Figure 4. Cholesterol is essential for ExoS-Bla translocation in
permissive HL-60 cells. A/ VD3-differentiated HL-60 cells were
grown as described in Materials and Methods and treated with 1 mM,
2 mM and 3 mM of Methyl-ß-cyclodextrine (MeßCD) for 2 h, before
infection at MOI 10 with the CHADS-SBlaR146A strain. MeaCD an
inactive isomer was used as control. The percentage of ExoS-Bla-
injected cells was quantified by flow cytometry. The error bars indicate
standard deviation (n=3). B/ Cholesterol-rich membranes (lipid rafts)
were purified by flotation on sucrose step gradients after infection of
cells at MOI 50 with the CHADS-SBla strain. For each fraction, the same
amounts of proteins were separated by SDS-PAGE and analysed by
immunodetection with antibodies specific for PopB or flotillin, a host
marker for lipid rafts. * indicates a proteolysed form of PopB.
doi:10.1371/journal.pone.0030488.g004
Figure 5. Injection of ExoS-Bla into differentiated HL-60 cells is
sensitive to pharmacological agents. A/ VD3-differentiated HL-60
cells were exposed to 10 mM of cytochalasin D (CytoD), 10 mMo f
latrunculin B (LtrB) or 50 nM of Wortmannin for 30 min prior and during
infection, or to 2 mM of TAT-C3 toxin, 100 mM of LY-294002, 12 mMo f
genistein, 10 mM of PP2, and 10 mM of PF-573-228 for 120 min prior and
during a 3 h infection period at MOI 10 with the PAO1DSTY-SBlaR146A
strain. The percentage of injection-positive cells was evaluated by flow
cytometry. B/ Eukaryotic plasma membranes were purified by
fractionation on sucrose gradient, after infection of cells pre-treated
with inhibitors as above. Proteins were analysed by immunoblotting
using anti-PopB. Ni : non-infected VD3-differentiated HL-60 cells, CTRL:
infected VD3-differentiated HL-60 cells without inhibitor. C/ The ability
of PAO1DSTY-SBlaR146A strain to secrete ExoS-Bla in vitro was assayed
for each inhibitor modifying injection by immunoblotting of total
secreted ExoS-Bla protein using the anti-ß-lactamase antibody. Pa:
supernatant of T3SS non-induced P.aeruginosa, IPa: supernatant of T3SS
induced P. aeruginosa without inhibitor.
doi:10.1371/journal.pone.0030488.g005
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pharmacological compound Y-27632, an inhibitor of ROCK
(Rho-controlled protein kinase). These two inhibitors had an
inhibitory or a stimulatory action, respectively, on the ability of
differentiated HL-60 cells to migrate through a 3 mm pore
membrane to a source of chemoattractants (Figure S1). Thus,
although they were unable to perturb ExoS-Bla injection, these
two inhibitors of the Rho-dependent pathway were readily active.
Because the conversion of phosphatidylinositol (4,5)-bispho-
sphate into PtdIns(3,4,5)P3 by PI3-kinase promotes the actin-
dependent uptake of Yersinia pseudotuberculosis [34,35], Listeria
monocytogenes [36], and P. aeruginosa [37], we tested two specific
PI3-kinase inhibitors, wortmannin and LY-294002. As illustrated
in Figure 5A, both compounds inhibited the translocation of
ExoS-Bla. To investigate whether tyrosine kinases play any role in
the functionality of the P. aeruginosa T3SS, several inhibitors were
tested. ExoS-Bla injection into VD3-dHL-60 was abolished by
genistein, a large spectrum tyrosine kinase inhibitor, by PP2, an
inhibitor of the Src-kinase(s), and by PF-5732208, an inhibitor of
focal adhesion tyrosine kinases, FAK and Pyk2 (Figure 5A). Most
of the compounds showed a dose-dependent inhibition (Figure
S2).
All the inhibitors that led to alteration in ExoS-Bla translocation
were tested for their absence of effect on the association of PopB
translocator with host cell membranes by applying sucrose-
gradient fractionation. As shown in the Figure 5B, the association
of PopB translocator with membranes of VD3-dHL-60 cells was
not impeded when cells were treated with the different inhibitors.
Thus, the insertion of the translocon proteins can be uncoupled
from the translocation process per se.
A recent study by Bridge et al. suggests that the insertion of
translocators into host cell plasma membrane requires cell
adhesion and formation of leading edge [38]. Using two different
approaches, we investigated whether adhesion of undifferentiated
HL-60 cells could promote the translocation of ExoS-Bla. Cell
adhesion was induced by transferring cells for a short period of
time in culture medium devoid of foetal calf serum (FCS).
Alternatively, cells were anchored in the presence of FCS on tissue
culture plates previously coated with a monoclonal antibody
specific for CD43, a cell-surface sialoglycoprotein highly expressed
on HL-60 cells. As illustrated in Figure 6, both approaches
yielded HL-60 cells that had rapidly switched from a transloca-
tion-resistant to a translocation-sensitive phenotype. In the
presence of FCS, HL-60 cells originally resistant to ExoS-Bla
translocation became sensitive when seeded in tissue culture plates
pre-treated with anti CD43. Judging from the markedly reduced
level of injected cells following the transfer of anti CD43-anchored
cells in a well devoid of antibody (Figure 6, part b), it is clear
that this acquired sensitivity was totally reversible and strictly
dependent on cell immobilization on the tissue culture plate. To
determine whether this acquired sensitivity to ExoS-Bla injection
involved the same molecular mechanism as that used in VD3-
dHL-60 cells, we tested the effects produced by cytochalasin D
(Figure 6, part c). Surprisingly, cytochalasin D that did alter the
injection of ExoS-Bla in VD3-dHL-60 cells, was unable to inhibit
the injection of ExoS-Bla in cells immobilized through binding to
anti CD43. Thus, the regulation of the functionality of T3S
translocon appears to be divergent in VD3-dHL-60 cells and non-
differentiated HL-60 cells that are turned on to be permissive to
injection.
Altogether, our results show that the injection of exotoxins into
the cytoplasm of VD3-dHL-60 cells is dependent on the integrity
of the actin network and regulated by the level of cholesterol and
the activation of host cell signalling pathways.
Discussion
Within the sophisticated and complex T3S secretion machinery,
the exact function and structure of translocator proteins is still a
great mystery. It is believed that the T3S nano-machinery results
Figure 6. Switching T3SS resistant HL-60 cells to T3SS
permissive cells by serum starvation or panning to anti-
CD43. Non-differentiated HL-60 cells were treated as follows:
maintained during 15 min in medium supplemented (+ FCS) or not
(2 FCS) (a), incubated during 5 min in either naive (2 anti CD43) or
coated wells with a monoclonal anti CD43 (+ anti CD43), first panned in
a anti CD43-coated well during 5 min and then transferred to a naı ¨ve
well, (transferred) (b) and cells were next incubated at MOI 10 with the
CHADS-SblaR146A strain and analysed by flow cytometry. Non-
differentiated HL-60 were incubated during 5 min in a well coated
with anti CD43 in the absence (2 CytoD) or the presence (+ CytoD) of
10 mM of cytochalasine D for 30 min prior and during infection at MOI
10 with the CHADS-SblaR146A strain (c). The error bars indicate
standard deviation (n=3). Insert: schematic drawing of the experiments
presented in the histogram (part b).
doi:10.1371/journal.pone.0030488.g006
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between the bacterium and the host cell membrane. Bacterial
toxins are believed to reach the host cell cytoplasm after
translocator proteins have formed a functional pore [39,40,41].
However, this microinjection model has recently been challenged
as secreted effector proteins (extracellular) of Yersinia pseudotubercu-
losis were shown to be translocated in a T3SS-dependent
mechanism [42]. In order to dissect translocon function in vivo,
we adapted to the P. aeruginosa T3SS a simple translocation
reporter system, which was first developed for E. coli, L.
pneumophilia, Y. pestis and P. aeruginosa T3SS [26,29,43,44,45] and
is based on the activity of ß-lactamase that cleaves a fluorescent
substrate. In brief, the ß-lactamase was fused downstream of the
N-terminal region of P. aeruginosa ExoS or ExoY toxins, which
were both deprived of their enzymatic activities. The resulting
chimeric proteins ExoS-Bla and ExoY-Bla were efficiently
translocated into several cell lines such as the epithelial cell line
A549, the B cell line BJAB, the T cell line Jurkat, and the
differentiated promyelocytic HL-60 and promonocytic U937 cells
as assessed by fluorescent microscopy and quantitative measure-
ments using flow cytometry. When infection was performed with
undifferentiated HL-60 or U937 cells, no injection of the reporter
fusion could be observed.
The use of P. aeruginosa strains deprived of either ExoS (CHADS)
or of the three ExoS, T and Y exoenzymes (PAO1DSTY) allowed
a better intoxication of cells with ExoS-Bla or ExoY-Bla due to the
absence of competition between the native exotoxins and the
reporter fusion proteins for the access to the translocation
machinery. Furthermore, the reporters ExoS-Bla or ExoY-Bla
were engineered to remove the GAP and the adenylate cyclase
activity, respectively, which excludes the possible implication of
the reporter in the regulation of translocon activity and diversion
of host cell signalling pathways.
To investigate whether host cell components play a role in the
regulation of the general translocation process, we examined in
parallel both the translocation efficiency and the presence of
translocators PopB/D within plasma membranes of infected cells.
PopB and PopD of P. aeruginosa are absolutely required for
exotoxin injection into host cell cytoplasm without having any
effects on effector secretion [18]. Both proteins possess predicted
hydrophobic transmembrane helices and are prone to associate
with lipids, both in vitro [19,20] and in vivo [18]. Interestingly, in the
present study, the observation that PopB and PopD are found
associated with the membranes of injection-resistant and injection-
sensitive cell lines suggests that the pore assembly and/or
functionality may be regulated by host cell factors. The resistance
of HL-60 cells to intoxication by exotoxins was recently correlated
with the incapacity of bacterial cells to stably insert translocon
proteins in the plasma membrane of non differentiated cells [38].
In our hands, immunoblotting analysis of plasma membrane
purified on sucrose gradient did not reveal any degradation of
either PopB or PopD whether cells were differentiated or not.
However, PopB was found to be sensitive to proteolysis exclusively
during the purification of specific membrane lipid rafts from the
plasma membrane of non differentiated cells. The proteolysis of
PopB may be due to an improper insertion in the plasma
membrane of non differentiated HL-60 cells and, thereby, to an
increased accessibility to proteases.
There is still little structural information on PopB/D proteins
[9], probably due to their hydrophobic characteristics, molten
globule conformation and/or oligomerization capacity [12,19].
PopB shares secondary fold with its Salmonella orthologue SipB, for
which exhaustive proteolysis experiments showed that it is deeply
inserted into lipid bilayer, with the N-terminal region being
exposed and cleaved off [46]. Indeed, in vitro studies have shown
that PopB possesses a high pore forming activity whereas PopD
activity is barely detectable and they do not associate with
liposomes with the same efficiency [20].
Several parameters are likely to play a role in translocon
assembly and/or functionality. It is known that an increase in
cholesterol-to-phospholipid ratio enhances plasma membrane
microviscosity in a large variety of cells [47]. Conversely, the
chelation of cholesterol decreases the plasma membrane micro-
viscosity and, thereby, redistributes proteins sequestered in
specialized rafts to different regions of the plasma membrane. In
the present study, we show that depletion of cholesterol from lipid
rafts by methyl-ß-cyclodextrin abolished the translocation of the
reporter ExoS-Bla in a dose-dependent manner. Co-localisation of
PopB with the lipid raft marker flotillin in fractions of sucrose
gradient is further supporting the role of lipid rafts in the
translocation process. This is consistent with a previous study
indicating that cholesterol is required for lysis of liposomes in
presence of PopB [19]. Furthermore, specific membrane micro-
domains have been already involved in Salmonella- and Shigella-host
cell interactions [21,23]. Cholesterol accumulation results in
increased membrane stiffness which could permit the formation
of an actin network at the leading edge, an area recently proposed
as the site of interaction between P. aeruginosa and differentiated
HL-60 cells [38].
The actin network appears to play a major role in the
translocation process in the VD3-HL-60 model as evidenced by
the action of cytochalasin D and latrunculin B, two actin-
depolymerizing agents which were found to markedly inhibit the
injection of ExoS-Bla. It is worth noting that the effect of
latrunculin B is much more pronounced in differentiated myeloid
cells than in epithelial cells such as HT29 [38]. Unexpectedly, we
were unable to observe any effect of either TAT-C3, or Y-27632,
an inhibitor of ROCK, even though these inhibitors did enter into
the cells and had a physiological effect as evidenced by their
capacity to perturb the migration of VD3-HL-60 cells to a source
of chemoattractants. Thus, the Rho-dependent pathway is unlikely
to play a role in the formation of a functional pore. We could not
conclude whether it is the integrity of the actin network rather
than its dynamics that is the key parameter for translocon insertion
and/or functionality.
In the VD3-dHL-60 model, the injection of ExoS-Bla is
dramatically impaired when tyrosine kinases and PI3-kinase are
pharmacologically inhibited. This observation is contrasting with
the lack of effect reported by Bridge and coworkers with the
epithelial HT29 model [38] or with lung-derived A549 epithelial
cells (our unpublished data). In the context of VD3-dHL-60 cells,
it is not known whether the functionality of the PopB/D pore
depends on the basal activity of specific host cell signalling
pathways or relies on the triggering of an ‘‘outside-in’’ signal
underneath the site of bacterial attachment. In the case of Yersinia
enterocolitica, Pyk2 and FAK, two tyrosine kinases localized in focal
adhesion complexes, are required for invasin-mediated signalling
through ß1-integrin [48]. The mechanism involved in the
interaction between P. aeruginosa and VD3-dHL-60 is still
unknown. Although a recent study suggests that ß-integrins are
unlikely candidates since blocking antibodies directed to ß1 or ß2
integrins does not affect T3SS-mediated toxin injection [38], it is
clear in our hands that the inhibition of FAK or Pyk2 markedly
reduce the injection of the reporter.
Several recent reports on other pathogens harbouring T3SS
suggest that the translocon proteins per se may be involved in host-
pathogen cross-talk and signalling. The insertion of the translo-
cation YopB/D pore into plasma membrane by Y. enterocolitica
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1ß, through the specific activation of caspase-1 [49]. A pathogenic
strain of Y. pseudotuberculosis, depleted on all known T3SS-
dependent effectors but possessing a functional translocon,
activates cytosolic innate immune signalling through the activation
of NF-kB and type I IFN-induced pathways [50]. P. aeruginosa
devoid of effectors was shown to activate the NLRC4 inflamma-
some [51,52,53]. A direct role in translocation regulation was
recently attributed to Yersinia pestis YopK/YopQ [26]. However,
although a majority of components participating in assembly of
T3S apparatus are highly conserved between Yersinia and P.
aeruginosa, no homologue of YopK could be identified in P.
aeruginosa genome, suggesting that there are alternative mecha-
nisms to regulate translocation efficiency. In the case of SPI-2
T3SS of Salmonella, a pH modification was recently reported to
play a key role in effector translocation and pore formation [54].
In a recent study, Cisz and coworkers [8] have shown that the
functionality of T3SS required an unkown ExoS-inhibited host cell
factor that may trigger either translocon insertion or stabilisation.
We showed here that this may also occur without the participation
of any (known) effector protein.
An important finding is that undifferentiated HL-60 cells that
exhibit a resistant phenotype to T3SS-mediated toxin injection
become rapidly susceptible to intoxication upon foetal calf serum
depletion and adhesion to the culture plate or after panning in
wells coated with anti-CD43. It is worth noting that the permissive
HL-60 cells lose this acquired phenotype in the course of the
infection step when they are transferred in naive wells devoid of
anti-CD43. In this case the lack of toxin injection in undifferen-
tiated HL-60 cells is not due to a defect in the expression of a
specific gene. The mechanism underlying the T3SS-dependent
toxin injection in anti-CD43 anchored cells may be different from
that involved in VD3-dHL-60 cells. Indeed, while the injection
process is fully inhibited in VD3-dHL-60 by agents that
depolymerize the actin network, i.e. cytochalasin D and
latrunculin B, the injection of ExoS-Bla in anti-CD43 treated
cells was hardly inhibited by the same agents. A recent study by
Bridge and coworkers establish a relationship between P. aeruginosa
T3SS translocon function and the formation of a leading edge.
Based on this model, we hypothesize that, as soon as anti-CD43
binds to CD43, non differentiated HL-60 cells reorganize their
actin cytoskeleton, redistribute plasma membrane proteins into
discrete domains and, subsequently, acquire a polarity. This
notion is consistent with the fact that CD43 is a transmembrane
glycoprotein known to concentrate at the uropod raft in activated
polarized neutrophils [55] and T-cells [56]. The plasma
membrane organization may orient the site of bacterial attach-
ment and subsequently downstream signalling events that control
pore formation.
Altogether, our results show that host cell components, such as
cholesterol, actin cytoskeleton network and signal transduction
pathways can modulate the injection of exotoxins into eukaryotic
cytoplasm. The resistance to injection does not result from the
absence of translocon insertion into host membranes. Therefore,
the translocon activity and/or its proper assembly require multiple
components of eukaryotic cell for efficient toxin translocation.
Materials and Methods
Bacterial strains, plasmid construction and analysis of
proteins secretion
P. aeruginosa strains used in this study was cystic fibrosis clinical
isolate CHA and its isogenic mutants CHADPscF [7] CHAD-
PopBD [18]. For DexoS construction, the exoS gene and the
flanking sequences were amplified by oligonucleotides ExoSss1
59ggcccaggatcggcttgcaa and ExoSas2 59gatccgctgccgagccaaga
using DNA from the CHA strain as template. The PCR fragment
of 1.8 kb was blunt-ligated into pEX100T [57]. The Gm cassette
was extracted from pUCPGm [58] and inserted into pEX-ExoS.
Inactivated copy of the exoS gene was introduced into CHA
chromosome by allelic exchange as described [57]. CHADExoS
mutant was checked by PCR and Western blotting. PAO1
depleted for the three exotoxins ExoS, ExoT and ExoY was kindly
provided by Arne Rietsch [8,59]. The popBD deletion was
introduced into PAO1A ¨STY strain by double recombination
procedure using the pJG5 plasmid as described [18]. The
promoter region of exoS and the GAP-encoding part of the gene
was PCR-amplified with primers pExoS1 59ggatccacctgcaggctgag-
tac and exoSXba 59 tctagacatcacttcggcgtcactgtg. The PCR
product was cloned into pBluescript SK(+) and checked by
sequencing. The fragment was excised by BamHI-XbaI digestion
and cloned into pUCP20 [58], giving pExoSGAP. The bla gene was
amplified from pBR322 with primers blacXba 59 tctagacaccca-
gaaacgctggtgaaag and blacHind 59aagctttttaccaatgcttaatcagtgagg-
caccta, cloned as XbaI-HindIII into pExoSGAP to give pExoSGAP-
Bla. The R146 mutation was introduced into pExoSGAPBla by
site-directed mutagenesis (Stratagene). The exoY-bla construction
was created by PCR using pYEcos 59 gaattccgccgcctcgccgagggtg
and YXbaas 59tctagaggcggtcatcgccagcccg which amplify 300
nucleotides upstream and 633 nt downstream of the ATG start
codon of exoY, thus ending up just in front of the Asp212 codon
known to be required for adenylate cyclase activity. The exoY PCR
product was cloned in pBlunt-TOPO (Invitrogen) and sequenced,
before cloning into pExoS-Bla in replacement of exoS sequence.
The final plasmids were introduced into different P. aeruginosa
strains by transformation [60]. For analysis of extracellular
proteins, P. aeruginosa strains were grown to an optical density at
600 nm (OD600) of 1 in LB medium supplemented with 5 mM
EGTA and 20 mM MgCl2.
Cell culture and incubation with P. aeruginosa
Promyelocytic cells HL-60, U937, Jurkat T cells, Bjab B cells
and A549 epithelial cells (American Type Culture Collection,
Manassas, VA) were cultured in RPMI 1640 with 2.0 mM L-
Glutamine (Gibco) containing 10% FCS (Gibco), 100 U/ml
penicillin and 100 mg/ml streptomycin (Gibco). Cells were
maintained in a humidified atmosphere with 5% CO2 at 37uC.
For infection, cells were washed once with complete RPMI
medium without antibiotic and seeded in 24-well tissue culture
plates (Falcon) at 10
6 cells/ml in complete RPMI medium without
antibiotic. P. aeruginosa strains were grown overnight at 37uCi nL B
containing 300 mg/ml of carbenicillin when needed, diluted the
next day to an optical density at 600 nm (OD600) of 0.1 in the
same medium and grown to OD600 of 1. The multiplicity of
infection ranged from 10 to 50 and, infection was performed for
3 h in 5% CO2 at 37uC.
Differentiation of myeloid cells
Cell differentiation into monocytes, macrophages and neutro-
phils was done by re-suspending the cells at 2.10
5 cells/ml in
complete RPMI culture medium containing 100 nM of 1,23
dihydroxy-Vitamin D3 (Sigma Chemical Co.) for 4 days, 5 ng/ml
Phorbol Myristate Acetate (Sigma Chemical Co.) for 2 days and
1.25% DMSO (from Sigma Chemical Co.) for 5 days, respectively.
Cell differentiation was assessed before each experiment by
CD11b expression analysis using FITC conjugated antibody
(IOTestH; Beckman Coulter) and flow cytometric analysis
(FACScalibur).
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24-well plate was incubated overnight in the presence of CD43
monoclonal antibody (clone L60, BD Pharmingen) at 1 mg/ml in
PBS. After removing of the antibody solution and after three
washes with PBS, the HL-60 cells were added in wells. The
infection conditions were as described above.
CCF2/AM loading and b-lactamase detection
After 3 h of infection, cells were incubated with freshly prepared
66CCF2/AM solution (1 mM final concentration; Invitrogen).
HL-60, Jurkat and Bjab cells were incubated for 30 min in the
dark at room temperature. A549 cells were incubated 90 min in a
2 mM CCF2-AM in PBS. The percentage of cells that received
reporter fusions was quantified by flow cytometry (FACS Moflo;
Dako Cytomation). The results are expressed as percentage of cells
that exhibit a blue fluorescence; uninfected cells incubated with
CCF2 were used as negative control. Fluorescence micrographs
were performed with a Cell-R inverted Olympus microscope using
206objective.
CD11b expression by FACS analysis
5.10
5 non-differentiated or differentiated HL-60 cells were
labelled with saturating amount of FITC conjugated monoclonal
antibody specific for CD11b (clone Bear1). Labelled cells were
acquired on FACSCalibur cytometer (Becton Dickinson).
Treatment of cells by inhibitors
Prior to and during infection, cells were exposed to either
10 mM of cytochalasin D, 10 mM of latrunculin B or 50 nM of
Wortmannin (Sigma Chemical Co.) for 30 min, at 37uC. Cells
were also exposed to either 100 mM of ROCK inhibitor Y-27632,
2.5 nM of Toxin B from Clostridium difficile (Sigma Chemical Co),
2 mM of TAT-C3 toxin from Clostridium botulinum (Cytoskeleton),
10 mM of PP2, 10 mM of PF-573-228 (Calbiochem), 100 mMo f
LY-294002 (Sigma Chemical Co) or 12 mM of Genistein (Sigma
Chemical Co) for 120 min prior to and during infection in a
humidified atmosphere with 5% CO2 at 37uC. For methyl-b-
cyclodextrine (MeßCD) treatment, HL-60 cells were grown in
RPMI supplemented with 1% Nutridoma-SP (Roche) to diminish
cholesterol concentration of the medium. Then, cells were treated
with 1, 2 or 3 mM MeßCD (Sigma) for 2 h before infection at
37uC in RPMI supplemented with 1% Nutridoma-SP and for 3 h
during infection. The cell viability was controlled by Trypan Blue
exclusion.
Preparation of plasma membranes by sucrose
discontinuous gradient centrifugations
Eukaryotic plasma membranes were purified after infection
using a previously described procedure [30]. Briefly, 60.10
6 HL60
cells at a density of 10
6 cells/ml were infected during 3 h at MOI
50 in RPMI supplemented with 10% FCS. Cells were then washed
3 times in cold PBS, and finally resuspended in 900 ml of cold
buffer A containing 3 mM imidazole, 250 mM sucrose, 0.5 mM
EDTA and proteases inhibitors cocktail (PIC, final concentration
of 1/100 v/v, P8340 SIGMA), pH 7.4. All steps were performed
at 4uC. Cells were lysed by 40 passages through a 25-gauge needle.
Lysates were centrifuged 15 min at 850 g, and 750 mlo f
supernatant were homogenized with 1.5 ml of buffer containing
3 mM imidazole, 63% sucrose and PIC, and placed into ultra-
clear centrifuge tubes (Beckman Coulter). One ml of buffer
containing 3 mM imidazole, 40% sucrose and PIC was gently
added and subsequently recovered with 1 ml buffer A. Samples
were centrifuged 16 h at 15000 g in a SW50.1 rotor from
Beckman Coulter. Then, the top 1.75 ml were gently harvested,
homogenized with 875 ml cold PBS containing PIC, and
centrifuged 30 min at 166000 g (rotor TLA110, Beckman
Coulter). Pellet was harvested in 100 ml cold PBS containing
PIC, and protein concentration determined with Bradford
Reagent (Sigma-Aldrich). Thus, the same quantities of proteins
for each sample were processed for immunoblotting.
Detergent resistant membrane (DRM) extraction
After infection, all steps were conducted at 4uC. After infection of
1.8.10
8 HL-60 cells (MOI 50 for 3 h and a density of 10
6 cells/ml),
infected cells were washed once with cold RPMI and lysed in 1.5 ml
MBS (25 mM MES, 150 mM NaCl, pH 6.5) containing 1% Triton
X-100, 1/100 PIC, and 1 mM benzamidine (B6506, Sigma-Aldrich).
Detergent treated membranes were centrifuged for 10 min at 3220 g
and supernatant was homogenized with 2 ml of MBS containing
85% sucrose into an ultracentrifuge tube, and further covered with
6.3 ml of MBS containing 35% sucrose and 2 ml of MBS containing
5% sucrose. Each sucrose solution contained PIC and 1 mM
benzamidine. Samples were centrifuged at 260000 g for 18 h at 4uC
in a Beckman Coulter SW41 rotor. DRM-containing fractions were
harvested at 35% sucrose/5% sucrose interface, diluted with 1.4 ml
MBS containing 1/100 PIC and 1 mM benzamidine, and
centrifuged at 376000 g for 30 min. Pellet was recovered with
100 ml MBS containing PIC and 1 mM benzamidine, and protein
content was determined with Bradford Reagent.
Immunoblotting analysis
Following sucrose gradients, equal quantities of protein (deter-
mined by Bradford method), were subjected to 12% SDS-PAGE,
and further transferred to nitrocellulose membrane. For antibody
calibrations, purified proteins 6His-PcrV, PopB and PopD [16,19]
were diluted in PBS buffer and 0.3 ng of each was loaded on the
same gel. The antibodies were previously described [18]. They were
affinity-purified and used at the following dilutions: anti-PopB
(1:5000), anti-PopD (1:3000) anti-PcrV (1:3000). Mouse monoclo-
nal anti-RpoA was purchased from Neoclone Biotechnology and
used at 1:1000 dilution. Rabbit polyclonal anti-flotillin-2 (Santa
Cruz Biotechnology) and mouse monoclonal anti-NTAL (Santa
Cruz Biotechnology) were used at 1:200 dilution. ECL
TM anti-
Rabbit or anti-mouse IgG HRP conjugated secondary antibodies
(GE Healthcare) were used at 1:5000 dilutions. The membrane was
developed by ECL kit (GE Healthcare).
Chemotaxis assay
The chemotaxis assay has been previously described [61]. In
brief, VD3-differentiated HL-60 cells were centrifuged, resus-
pended in fresh complete RPMI 1640 medium at the density of
10
6 cells/ml and incubated overnight with 5 nM of 1,19-
dioctadecyl-3,3,39,39-tetramethylindolcarbocyanine perchlorate
(Molecular probes, Eugene, OR). Cells were then centrifuged
and washed once with complete medium and twice with the
chemotaxis buffer (RPMI 1640 supplemented with 5% heat
inactivated foetal calf serum). Cells at a density of 10
6 cells/ml
were preincubated, for 2 h at 37uC, in the chemotaxis buffer in the
presence of either the vehicle (50% glycerol in phosphate buffered
saline) or the inhibitors, including TAT-C3 (0,33 mM), a cell
permeable toxin targeting RhoA, B, and C, or 100 mM of the
pharmacological compound Y27632, an inhibitor of ROCK. One
hundred ml of cells (10
5 cells) treated or not with inhibitors were
loaded into the upper chamber of FluoroBlok inserts of 3 mm pore
size (Becton Dickinson, Le Pont-de-Claix, France). Five hundred
ml of a 10-fold dilution of P. aeruginosa culture supernatant were
placed in the lower chambers and the FluoroBlok inserts were
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to the bottom of the lower chamber were counted in five fields
(magnification6100) using an inverted fluorescence LEICA
DMIER2 microscope Three independent set of experiments were
performed and results are presented as the percentage of cells
migrating through the filter in control chambers, i.e. without
inhibitors.
Supporting Information
Figure S1 Effects of Rho GTPase and Rho kinase
inhibitors on the migration of VD3-differentiated HL-
60 cells. To determine whether TAT-C3 (0,33 mM), or the
ROCK inhibitor Y27632 (100 mM) were readily active and had a
physiological effect on VD3-differentiated HL-60 cells, we
examined whether they had the capacity to alter the migration
of VD3-differentiated HL-60 cells through a 3 mm pore mem-
brane to a source of chemoattractants, namely the supernatant of
cultures of P. aeruginosa growing in the exponential phase (see
Materials and Methods). In each set of experiment, we counted the
number of cells present in the lower chamber either in the absence
of inhibitor (control) or in the presence of inhibitors in five
microscopic fields chosen at random (magnification6100). Results
are presented as migrating cells expressed in percent of cells
migrating in the control.
(TIF)
Figure S2 Dose effect of pharmacological agents. HL-60
VD3 were exposed to different concentrations of cytochalasin D
(cytoD), latrunculin B (LtrB), wortmannin for 30 min prior and
during infection or to different concentrations of LY-294002,
Genistein, PP2 or PF-573-228 for 120 min prior and during
infection. HL-60 VD3 were infected at MOI of 10, for 3 h, with
PAO1F D3STY ExoSBlaR146A strain and then analysed by flow
cytometry.
(TIF)
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